Results 61 to 70 of about 1,482 (173)

Clinical Characteristics, Treatment Patterns, and Outcomes of Chinese Patients With Alopecia Areata: A Retrospective Observational Study

Journal of Cosmetic Dermatology, Volume 25, Issue 7, July 2026.
ABSTRACT Background Alopecia areata (AA) is an inflammatory, nonscarring hair loss disorder with significant variations in the clinical presentation and unpredictable nature of the disease. Although AA is common in clinical dermatology, knowledge gaps remain regarding the clinical characteristics and impact on patients' psychological well‐being and ...
Youyu Sheng, Zhibing Qiu, Jun Zhao, Lijuan Zhou, Ying Miao, Bilian Zhao, Jinnan Li, Guanshen Dou, Wenyu Wu, Qinping Yang   +9 more
wiley   +1 more source

Real‐World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction

The Journal of Dermatology, Volume 53, Issue 5, Page 746-757, May 2026.
ABSTRACT Baricitinib and ritlecitinib are newly approved systemic Janus kinase (JAK) inhibitors for severe, refractory alopecia areata (AA). Although clinical trials have demonstrated their efficacy, real‐world evidence remains limited, particularly regarding predictors of response and outcomes following treatment interruption or dose tapering.
Rina Hayashi, Saori Takamura, Tomoo Fukuda   +2 more
wiley   +1 more source

Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report

Case Reports in Dermatology, 2020
Alopecia areata (AA) is the most common immune-mediated hair loss disorder with a life-time prevalence of 2%. The pathogenesis of AA is not completely understood, but interferon gamma (INF-γ) and Janus kinases (JAK) may play a key role.
Tanja Todberg, Nikolai Dyrberg Loft, Claus Zachariae   +2 more
doaj   +1 more source

Alopecia Universalis in an Elderly Chinese Man Induced by Sacubitril/Alisartan, a Novel Angiotensin Receptor-Neprilysin Inhibitor

Journal of Inflammation Research, 2023
Yan Teng,1 Yibin Fan,1 Danying Shang,1 Xiaohua Tao,1,* Dongsheng Sun2,* 1Center for Plastic & Reconstructive Surgery, Department of Dermatology, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou ...
Teng Y, Fan Y, Shang D, Tao X, Sun D
doaj  

Association of Alopecia Universalis, Generalized Vitiligo, and Graves' Disease

Journal of Research in Medical Sciences, 2005
We present a 21-years old woman with alopecia universalis, generalized vitiligo, and Graves' disease. She had had thyroidectomy in early childhood and was receiving replacement therapy with levothyroxine.
Z Shahmoradi, Afshin Darougheh, S Misaghian   +2 more
doaj  

A Novel Fusion Technique for Early Detection of Alopecia Areata Using ResNet-50 and CRSHOG

IEEE Access
Alopecia Areata is an autoimmune disorder where the body’s immune system attacks normal cells instead of intruders, leading to hair loss. If not detected early, it can progress to complete scalp baldness (Alopecia Totalis) or total body hair loss (
Haider Ali Khan, Syed M. Adnan
doaj   +1 more source

Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review. [PDF]

Cureus, 2022
Abdalla H, Ebrahim E.
europepmc   +1 more source

Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older

Actas Dermo-Sifiliográficas
Alopecia areata (AA) is a dermatological disease of immune origin characterized by partial or total hair loss of the scalp (alopecia totalis) or the whole body (alopecia universalis).
S. Vañó-Galván, I. Figueras-Nart, C. Serrano, M.P. Fortes, V. Herrera-Lasso, R. Botella-Estrada   +5 more
doaj   +1 more source

[Alopecia areata universalis under treatment with sitagliptin : Possible immunological effect of dipeptidyl peptidase-4 inhibitors?] [PDF]

Hautarzt, 2021
Kohlmann J, Ferrer RA, Markovic A, Illes M, Kunz M.   +4 more
europepmc   +1 more source

Back to the Basics: Response of Alopecia Areata Universalis to Intravenous High-Dose Pulse Corticosteroid Therapy. [PDF]

Dermatol Pract Concept, 2021
Plachouri KM, Oikonomou C, Vryzaki E, Georgiou S.   +3 more
europepmc   +1 more source